Phage display affords peptides that modulate beta-amyloid aggregation - PubMed (original) (raw)
. 2006 Sep 13;128(36):11882-9.
doi: 10.1021/ja0619861.
Affiliations
- PMID: 16953628
- DOI: 10.1021/ja0619861
Phage display affords peptides that modulate beta-amyloid aggregation
Brendan P Orner et al. J Am Chem Soc. 2006.
Abstract
As the population ages, the need to develop methods to understand and intercept the processes responsible for protein aggregation diseases is becoming more urgent. The aggregation of the protein beta-amyloid (Abeta) has been implicated in Alzheimer's Disease (AD); however, whether the toxic species is a large, insoluble aggregate or some lower order form is not yet known. Agents that can modulate the aggregation state of Abeta could resolve this controversy by facilitating our understanding of the consequences of aggregation and its underlying mechanism. To date, however, ligands that bind to specific forms of Abeta have not been identified. To address this deficiency, we tested whether phage display could yield such ligands by screening libraries against Abeta in two different states: monomeric or highly aggregated. Intriguingly, the peptides selected had different effects on Abeta aggregation. Peptides selected for binding to monomeric Abeta did not perturb aggregation, but those selected using highly aggregated Abeta increase the rate of aggregation drastically. The latter also alter the morphology of the resulting aggregate. The ability of a peptide to promote aggregation correlated with its affinity for the N-terminal 10 residues of Abeta. This result indicates that the mechanism by which the peptides influence aggregation is related to their affinity for the Abeta N-terminus. Thus, the identification of compounds that bind to this Abeta section can afford agents that affect aggregation. Moreover, the data suggest that endogenous ligands that interact with the N-terminal region can influence the propensity of Abeta to form aggregates and the morphology of those that form. Our data highlight the utility of phage display for identifying ligands that bind to target proteins in different states, and they indicate that such agents can be used to perturb protein aggregation.
Similar articles
- Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
Grönwall C, Jonsson A, Lindström S, Gunneriusson E, Ståhl S, Herne N. Grönwall C, et al. J Biotechnol. 2007 Jan 30;128(1):162-83. doi: 10.1016/j.jbiotec.2006.09.013. Epub 2006 Sep 27. J Biotechnol. 2007. PMID: 17088007 - Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T, Mihara H. Takahashi T, et al. Acc Chem Res. 2008 Oct;41(10):1309-18. doi: 10.1021/ar8000475. Acc Chem Res. 2008. PMID: 18937396 - Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D. Wiesehan K, et al. Chembiochem. 2003 Aug 4;4(8):748-53. doi: 10.1002/cbic.200300631. Chembiochem. 2003. PMID: 12898626 - Designing scaffolds of peptides for phage display libraries.
Uchiyama F, Tanaka Y, Minari Y, Tokui N. Uchiyama F, et al. J Biosci Bioeng. 2005 May;99(5):448-56. doi: 10.1263/jbb.99.448. J Biosci Bioeng. 2005. PMID: 16233816 Review. - Molecular addresses of tumors: selection by in vivo phage display.
Li XB, Schluesener HJ, Xu SQ. Li XB, et al. Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):177-81. doi: 10.1007/s00005-006-0026-y. Epub 2006 May 31. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16736105 Review.
Cited by
- Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation.
Delivoria DC, Chia S, Habchi J, Perni M, Matis I, Papaevgeniou N, Reczko M, Chondrogianni N, Dobson CM, Vendruscolo M, Skretas G. Delivoria DC, et al. Sci Adv. 2019 Oct 16;5(10):eaax5108. doi: 10.1126/sciadv.aax5108. eCollection 2019 Oct. Sci Adv. 2019. PMID: 31663025 Free PMC article. - Transthyretin-derived peptides as β-amyloid inhibitors.
Cho PY, Joshi G, Johnson JA, Murphy RM. Cho PY, et al. ACS Chem Neurosci. 2014 Jul 16;5(7):542-51. doi: 10.1021/cn500014u. Epub 2014 Apr 9. ACS Chem Neurosci. 2014. PMID: 24689444 Free PMC article. - Towards preventing exfoliation glaucoma by targeting and removing fibrillar aggregates associated with exfoliation syndrome.
Ghaffari Sharaf M, Waduthanthri KD, Crichton A, Damji KF, Unsworth LD. Ghaffari Sharaf M, et al. J Nanobiotechnology. 2022 Oct 27;20(1):459. doi: 10.1186/s12951-022-01665-6. J Nanobiotechnology. 2022. PMID: 36303134 Free PMC article. - Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling.
Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L, Garcia-Abreu J, Ferreira ST. Magdesian MH, et al. J Biol Chem. 2008 Apr 4;283(14):9359-68. doi: 10.1074/jbc.M707108200. Epub 2008 Jan 30. J Biol Chem. 2008. PMID: 18234671 Free PMC article. - Inhibition of Abeta42 aggregation using peptides selected from combinatorial libraries.
Baine M, Georgie DS, Shiferraw EZ, Nguyen TP, Nogaj LA, Moffet DA. Baine M, et al. J Pept Sci. 2009 Aug;15(8):499-503. doi: 10.1002/psc.1150. J Pept Sci. 2009. PMID: 19562726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials